p38 mitogen-activated protein kinase activation during platelet storage: Consequences for platelet recovery and hemostatic function in vivo

Blood

Volumn 115, Issue 9, 2010, Pages 1835-1842

  Canault, Matthias ^a,b,c,e   Duerschmied, Daniel ^a,b,c,f   Brill, Alexander ^a,b,c   Stefanini, Lucia ^d   Schatzberg, Daphne ^a,b   Cifuni, Stephen M ^a,b   Bergmeier, Wolfgang ^d   Wagner, Denisa D ^a,b,c  

^a CENTER FOR BLOOD RESEARCH   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e INSERM   (France)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CHLOROTRIANISENE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; ADAM PROTEIN; THROMBIN RECEPTOR; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EMBRYO; ENZYME INHIBITION; HEMOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STORAGE TEMPERATURE; THROMBOCYTE AGGREGATION; THROMBOCYTE PRESERVATION; ANIMAL; BLOOD; BLOOD STORAGE; C57BL MOUSE; DRUG ANTAGONISM; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE TRANSFUSION; TRANSGENIC MOUSE;

ADAM PROTEINS; ANIMALS; BLOOD PLATELETS; BLOOD PRESERVATION; ENZYME ACTIVATION; HEMOSTASIS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, TRANSGENIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET TRANSFUSION;

EID: 77950348555     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-03-211706     Document Type: Article

References (36)

1. Holme S, Heaton A. In vitro platelet ageing at 22 degrees C is reduced compared to in vivo ageing at 37 degrees C. Br J Haematol. 1995;91(1):212-218.
2. Klinger MH. The storage lesion of platelets: ultrastructural and functional aspects. Ann Hematol. 1996;73(3):103-112.
3. Järemo P, Rubach-Dahlberg E, Solum NO. Correlation of light transmission changes to changes of platelet glycoprotein Ib during storage of platelet concentrates. Thromb Res. 1993;69(5):467-477. (Pubitemid 23102566)
4. Ribeiro A, Swann JC, Berndt MC. Alterations of the levels of glycoproteins Ib-IX and IIb-IIIa in platelets stored at 22 degrees C. Thromb Res. 1992;66(6):619-627.
5. Bergmeier W, Piffath CL, Cheng G, et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res. 2004;95(7):677-683. (Pubitemid 39331927)
6. Rabie T, Strehl A, Ludwig A, Nieswandt B. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem. 2005;280(15):14462-14468. (Pubitemid 40562786)
7. Mezyk R, Bzowska M, Bereta J. Structure and functions of tumor necrosis factor-alpha converting enzyme. Acta Biochim Pol. 2003;50(3):625-645. (Pubitemid 38623797)
8. Leytin V, Allen DJ, Gwozdz A, Garvey B, Freedman J. Role of platelet surface glycoprotein Ibalpha and P-selectin in the clearance of transfused platelet concentrates. Transfusion. 2004;44(10):1487-1495. (Pubitemid 39318985)
9. Bergmeier W, Burger PC, Piffath CL, et al. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood. 2003;102(12):4229-4235. (Pubitemid 37487012)
10. Kramer RM, Roberts EF, Strifler BA, Johnstone EM. Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem. 1995;270(46):27395-27398.
11. Kramer RM, Roberts EF, Um SL, et al. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets: evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J Biol Chem. 1996;271(44):27723- 27729.
12. Saklatvala J, Rawlinson L, Waller RJ, et al. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem. 1996;271(12):6586-6589. (Pubitemid 26104083)
13. Börsch-Haubold AG, Kramer RM, Watson SP. Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur J Biochem. 1997;245(3):751-759. (Pubitemid 27223910)
14. Begonja AJ, Geiger J, Rukoyatkina N, Rauchfuss S, Gambaryan S, Walter U. Thrombin stimulation of p38 MAP kinase in human platelets is mediated by ADP and thromboxane A2 and inhibited by cGMP/cGMP-dependent protein kinase. Blood. 2007;109(2):616-618. (Pubitemid 46105961)
15. Canobbio I, Reineri S, Sinigaglia F, Balduini C, Torti M. A role for p38 MAP kinase in platelet activation by von Willebrand factor. Thromb Haemost. 2004;91(1):102-110. (Pubitemid 38111227)
16. Kuliopulos A, Mohanlal R, Covic L. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation. Thromb Haemost. 2004;92(6):1387-1393. (Pubitemid 39642551)
17. Börsch-Haubold AG, Pasquet S, Watson SP. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059: SB 203580 also inhibits thromboxane synthase. J Biol Chem. 1998;273(44):28766- 28772. (Pubitemid 28507565)
18. Morris JB, Olzinski AR, Bernard RE, et al. p38 MAPK inhibition reduces aortic ultrasmall super-paramagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment. Arterioscler Thromb Vasc Biol. 2008;28(2):265-271.
19. Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology. 2000;47(2):185-201. (Pubitemid 30394538)
20. Peschon JJ, Slack JL, Reddy P, et al.An essential role for ectodomain shedding in mammalian development. Science. 1998;282(5392):1281-1284. (Pubitemid 28524483)
21. Kanaji T, Russell S, Ware J. Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome. Blood. 2002;100(6):2102- 2107.
22. Bergmeier W, Schulte V, Brockhoff G, Bier U, Zirngibl H, Nieswandt B. Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody. Cytometry. 2002;48(2):80-86. (Pubitemid 34591919)
23. Fan H, Derynck R. Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J. 1999;18(24):6962-6972. (Pubitemid 30000449)
24. Díaz-Rodríguez E, Montero JC, Esparis-Ogando A, Yuste L, Pandiella A. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol Biol Cell. 2002;13(6):2031-2044. (Pubitemid 34651490)
25. Weskamp G, Schlondorff J, Lum L, et al. Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). J Biol Chem. 2004;279(6):4241-4249. (Pubitemid 38199011)
26. Denis C, Methia N, Frenette PS, et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci U S A. 1998;95(16):9524-9529. (Pubitemid 28506264)
27. Zhu L, Bergmeier W, Wu J, et al. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci U S A. 2007;104(5):1621-1626. (Pubitemid 46214640)
28. Brill A, Chauhan AK, Canault M, Walsh MT, Bergmeier W, Wagner DD. Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc Res. 2009; 84(1):137-144.
29. Duerschmied D, Canault M, Lievens D, et al. Serotonin stimulates platelet receptor shedding by tumor necrosis factor-alpha-converting enzyme (ADAM17). J Thromb Haemost. 2009;7(7):1163-1171.
30. Kato H, Takai S, Matsushima-Nishiwaki R, et al. HSP27 phosphorylation is correlated with ADP-induced platelet granule secretion. Arch Biochem Biophys. 2008;475(1):80-86.
31. Buschbeck M, Ghomashchi F, Gelb MH, Watson SP, Börsch-Haubold AG. Stress stimuli increase calcium-induced arachidonic acid release through phosphorylation of cytosolic phospholipase A2. Biochem J. 1999;344(2):359-366. (Pubitemid 30011590)
32. Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anuclear cell death delimits platelet life span. Cell. 2007;128(6):1173-1186.
33. Smalley DM, Ley K. L-selectin: mechanisms and physiological significance of ectodomain cleavage. J Cell Mol Med. 2005;9(2):255-266.
34. Hoffmeister KM, Felbinger TW, Falet H, et al. The clearance mechanism of chilled blood platelets. Cell. 2003;112(1):87-97. (Pubitemid 36106421)
35. Josefsson E, Rumjantseva V, Dahlgren C, et al. Metalloproteinase inhibitors increase the survival of long-term refrigerated platelets in mice. Blood. (ASH Annual Meeting Abstracts). 2007;110: Abstract 419.
36. Barone FC, Irving EA, Ray AM, et al. SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther. 2001;296(2):312-321.